Progenics Pharmaceuticals 142 Percent Price Target From Cantor Fitzgerald
Cantor Fitzgerald really went out high on Progenics Pharmaceuticals, or did they? Needham and Company also gave this stock its highest Strong Buy rating too.
Lance Jepsen